Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Risk Perception in Adults With Attention Deficit and Hyperactivity Disorder (ADHD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01994694
Recruitment Status : Completed
First Posted : November 26, 2013
Last Update Posted : November 18, 2015
Sponsor:
Information provided by (Responsible Party):
Shaare Zedek Medical Center

Brief Summary:
People with ADHD often engage in risky behaviors, such as dangerous driving, substance abuse and gambling. Current behavioral economy theories differentiate between risk perception and risk attitude. This study aims to measure both risk taking and risk perception in adults with and without ADHD. It is hypothesized that people with ADHD show decreased risk perception, accounting for their risky behavior. In contrast, it is hypothesized that people with ADHD do not show increased risk attitude, namely, they are not risk seeking.

Condition or disease
ADHD

Show Show detailed description

Layout table for study information
Study Type : Observational
Actual Enrollment : 60 participants
Observational Model: Case Control
Time Perspective: Cross-Sectional
Official Title: Risk Perception in Adults With Attention Deficit and Hyperactivity Disorder (ADHD)
Study Start Date : November 2014
Actual Primary Completion Date : November 2015
Actual Study Completion Date : November 2015

Resource links provided by the National Library of Medicine


Group/Cohort
adults with ADHD
adults with ADHD, without neurological and psychiatric comorbidities
controls
people without ADHD, with no neurological and psychiatric disorders



Primary Outcome Measures :
  1. Domain-specific Risk-Taking questionnaire [ Time Frame: 1 day ]
    Subjects are given the questionnaire once



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 50 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Adults with ADHD
Criteria

Inclusion Criteria:

  • clinical diagnosis of ADHD

Exclusion Criteria:

  • any neurological disorder
  • any psychiatric disorder

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01994694


Locations
Layout table for location information
Israel
Shaare Zedek Medical Center
Jerusalem, Israel, 91031
Sponsors and Collaborators
Shaare Zedek Medical Center
Investigators
Layout table for investigator information
Principal Investigator: Yehuda Pollak, PhD Hebrew University of Jerusalem
Layout table for additonal information
Responsible Party: Shaare Zedek Medical Center
ClinicalTrials.gov Identifier: NCT01994694    
Other Study ID Numbers: riskperception.ctil
First Posted: November 26, 2013    Key Record Dates
Last Update Posted: November 18, 2015
Last Verified: July 2015
Additional relevant MeSH terms:
Layout table for MeSH terms
Attention Deficit Disorder with Hyperactivity
Attention Deficit and Disruptive Behavior Disorders
Neurodevelopmental Disorders
Mental Disorders